North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Product Description
In-house Standards
AI Product Description
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Tazemetostat Intermediate 1</strong> (CAS: 1173081-96-3) is a key synthetic building block for the epigenetic inhibitor Tazemetostat. Its molecular formula is <strong>C24H25ClN4O3</strong>. The core process involves the nucleophilic substitution of specific chlorinated precursors with amine derivatives under controlled catalytic conditions.</p>
<h3>Application</h3>
<ul>
<li>Pharmaceutical synthesis as an active pharmaceutical ingredient (API) intermediate.</li>
<li>R&D for oncology treatments targeting EZH2 in lymphomas and solid tumors.</li>
<li>Quality control standard development for regulatory compliance testing.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly store in sealed containers below 25°C away from moisture. Handle with PPE to avoid inhalation or skin contact; not for direct human use without final formulation.</p>